Patents Represented by Attorney, Agent or Law Firm Elias J Lambiris
  • Furyl-pyridone compounds, useful as fungicides and obtained from the fungus Cladobotryum
    Patent number: 6172006
    Abstract: The invention relates to biologically active novel compounds having formula (I) as defined herein. Also disclosed are methods of preparing said compounds, fungicidal compositions comprising, as an active ingredient, these compounds, use of the compounds, and method of controlling fungi at loci infested or liable to be infested therewith.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: January 9, 2001
    Assignee: Novo Nordiskals
    Inventors: Helle Demuth, Jens Breinholt, Birgitte Rassing Romer
  • Haloperoxidases from Curvularia verruculosa and nucleic acids encoding same
    Patent number: 5965418
    Abstract: The present invention relates to Curvularia verruculosa haloperoxidases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the haloperoxidases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods for recombinant production of the haloperoxidase. The invention further relates to compositions comprising the haloperoxidases and methods of using the compositions for killing microbial cells or inhibiting growth of microbial cells.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: October 12, 1999
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Claus Fuglsang, Karen Oxenb.o slashed.ll, Torben Halkier, Randy M. Berka, Joel Cherry
  • Methods for producing polypeptides in mutants of bacillus cells
    Patent number: 5958728
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a Bacillus cell, wherein the mutant (i) comprises a first nucleic acid sequence encoding the polypeptide and a second nucleic acid sequence comprising a modification of at least one of the genes responsible for the biosynthesis or secretion of a surfactin or isoform thereof under conditions conducive for the production of the polypeptide and (ii) the mutant produces less of the surfactin or isoform thereof than the Bacillus cell when cultured under the same conditions; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to mutants of Bacillus cells and methods for producing the mutants.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: September 28, 1999
    Assignee: Novo NordiskBiotech, Inc.
    Inventors: Alan Sloma, David Sternberg, Lee F. Adams, Stephen Brown
  • Gene encoding carboxypeptidase of aspergillus niger
    Patent number: 5939305
    Abstract: The present invention relates to a gene encoding an ascomycete or deuteromycete carboxypeptidase Y gene, and host cells modified so as to produce reduced amounts of carboxypeptidase.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: August 17, 1999
    Assignee: Novo Nordisk Biotech Inc
    Inventors: Debbie Sue Yaver, Sheryl Ann Thompson
  • Re-formation of keratinous fibre cross links
    Patent number: 5899212
    Abstract: The present invention relates to a method for re-forming keratinous fibre cross links comprising contacting at least one oxidoreductase with the keratinous fibres for a sufficient period of time and under conditions sufficient to permit re-formation of keratinous fibre cross links. The method may be performed simultaneously with dyeing of said keratinous fibres. The invention also relates to the use at least one oxidoreductase for re-formation of keratinous fibre cross links.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: May 4, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Henrik S.o slashed.rensen, Jason Patrick McDevitt